[HTML][HTML] Improving patient stratification and selection for curative-intent treatment in localized pancreatic cancer
Correspondence to: Jashodeep Datta, MD. Department of Surgery, University of Miami Miller
School of Medicine, 1120 NW 14th Street, Suite 410, Miami, FL 33136, USA; Sylvester …
School of Medicine, 1120 NW 14th Street, Suite 410, Miami, FL 33136, USA; Sylvester …
[HTML][HTML] Multimodal Approaches to Patient Selection for Pancreas Cancer Surgery
With an overall 5-year survival rate of 12%, pancreas ductal adenocarcinoma (PDAC) is an
aggressive cancer that claims more than 50,000 patient lives each year in the United States …
aggressive cancer that claims more than 50,000 patient lives each year in the United States …
Preoperative therapy for pancreatic adenocarcinoma—precision beyond anatomy
Despite recent advances in the systemic treatment of gastrointestinal tumors, pancreatic
adenocarcinoma (PDAC) remains a challenging disease, with 5‐year survival just over 10 …
adenocarcinoma (PDAC) remains a challenging disease, with 5‐year survival just over 10 …
Surgical decision-making in pancreatic ductal adenocarcinoma: modeling prognosis following pancreatectomy in the era of induction and neoadjuvant chemotherapy
JR Habib, B Kinny-Köster, P Bou-Samra… - Annals of …, 2023 - journals.lww.com
Study design: JRH, BK-K., CLW, and RAB; acquisition of data: PB-S., RA, ES, AAJ, and DD;
analysis and interpretation of data: JRH, BK, JLC, KJL, WRB, JH, JY, CLW, and RAB; …
analysis and interpretation of data: JRH, BK, JLC, KJL, WRB, JH, JY, CLW, and RAB; …
Locally Advanced Pancreas Cancer, Is There a Role for Surgery?
BC Fields, CWD Tzeng - Surgical Clinics, 2024 - surgical.theclinics.com
Pancreatic cancer (in this review, ductal adenocarcinoma) is the 10th most common cancer
in the United States but trails only lung and colorectal cancers as the third leading cause of …
in the United States but trails only lung and colorectal cancers as the third leading cause of …
Type of resection (Whipple vs. distal) does not affect the national failure to provide post-resection adjuvant chemotherapy in localized pancreatic cancer
JR Bergquist, T Ivanics, CR Shubert… - Annals of surgical …, 2017 - Springer
Introduction Adjuvant chemotherapy improves survival after curative intent resection for
localized pancreatic adenocarcinoma (PDAC). Given the differences in perioperative …
localized pancreatic adenocarcinoma (PDAC). Given the differences in perioperative …
[HTML][HTML] Selecting surgical candidates with locally advanced pancreatic cancer: a review for modern pancreatology
YHA Wu, A Oba, R Lin, S Watanabe… - Journal of …, 2021 - ncbi.nlm.nih.gov
Pancreatic cancer (PC) is likely to become the second leading cause of malignancy-
associated mortality within the next 10 years and surgery remains the best hope for cure …
associated mortality within the next 10 years and surgery remains the best hope for cure …
Novel Considerations in Surgical Management of Individuals with Pancreatic Adenocarcinoma
CA Barnes, S Tsai - Hematology/Oncology Clinics, 2022 - hemonc.theclinics.com
The management of localized pancreatic cancer (PC) has evolved significantly in the last
decade, moving away from prioritizing surgery as the primary treatment modality and …
decade, moving away from prioritizing surgery as the primary treatment modality and …
[HTML][HTML] Surgical considerations for neoadjuvant therapy for pancreatic adenocarcinoma
Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is a morbid malignancy with
discouraging survival rates. Enthusiasm for pre-operative therapy (chemotherapy, radiation …
discouraging survival rates. Enthusiasm for pre-operative therapy (chemotherapy, radiation …
Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy
Background We previously introduced a classification system for patients with localized
pancreatic adenocarcinoma that integrates assessments of tumor anatomy, cancer biology …
pancreatic adenocarcinoma that integrates assessments of tumor anatomy, cancer biology …